Characterization of the size, shape, and state of dispersion of nanoparticles for toxicological studies

References

• Allen, T. 2004a. Particle size measurement, Vol I: Powder sampling and particle size measurement. 5th ed. London: Chapman & Hall.
   Google Scholar
• Allen, T. 2004b. Particle size measurement, Vol II: Surface area and pore size determination. 5th ed. London: Chapman & Hall.
   Google Scholar
• Berry CC, Dalby MJ, McCloy D, Affrossman S. The fibroblast response to tubes exhibiting internal nanotopography. Biomaterials 2005; 26: 4985–4892
   PubMed Web of Science ®Google Scholar
• Borm PJA, Robbins D, Haubold S, Kuhlbusch T, Fissan H, Donaldson K, Schins R, Stone V, Kreyling W, Lademann J, Krutmann J, Warheit D, Oberdörster E. The potential risks of nanomaterials: A review carried out for ECETOC. Particle Fibre Toxicol 2006; 3: 11–46
   PubMed Web of Science ®Google Scholar
• Bucher, J, Masten, S, Moudgil, B, Powers, K, Roberts, S, Walker, N. 2004. Developing experimental approaches for the evaluation of toxicological interactions of nanoscale materials. Final workshop report 3–4 November 2004, University of Florida, Gainesville, FL USA. www.nanotoxicology.ufl.edu.
   Google Scholar
• Castranova V. From coal mine dust to quartz: Mechanisms of pulmonary pathogenicity. Inhalation Tox 2000; 12: 7–14
   PubMed Web of Science ®Google Scholar
• Gutwein L, Webster T. Osteoblast and chrondrocyte proliferation in the presence of alumina and titania nanoparticles. J Nanoparticle Res 2002; 4: 231–238
   Web of Science ®Google Scholar
• Hart GA, Hesterberg TW. In vitro toxicity of respirable-size particles of diatomaceous earth, and crystalline silica compared with asbestos and titanium dioxide. J Occup Environ Med 1998; 40: 29–42
   PubMed Web of Science ®Google Scholar
• Hentschel M, Page N. Selection of descriptors for particle shape characterization. Particle Particle Sys Char 2003; 20: 25–38
   Web of Science ®Google Scholar
• Heyder J. Deposition of inhaled particles in the human respiratory tract and consequences for regional targeting in respiratory drug delivery. Proc Amer Thoracic Soc 2004; 1: 315–320
   PubMedGoogle Scholar
• Hinds WC. Aerosol technology: Properties, behavior, and measurement of airborne particles. Wiley, New York 1999
   Google Scholar
• International Commission on Radiological Protection (ICRP). 1994. Human respiratory tract models for radiological protection. Ann ICRP 24.
   Google Scholar
• Jillavenkatesa A, Kelly J. Nanopowder characterization: challenges and future directions. J Nanopart Res 2002; 4: 463–468
   Web of Science ®Google Scholar
• Kammler H, Mädler L, Pratsinis S. Flame synthesis of nanoparticles. Chem Engineer Tech 2001; 24: 583–596
   Web of Science ®Google Scholar
• J Knapp, Barber, T, Lieberman, A, editors. 1996. Liquid-and surface-borne particle measurement handbook. New York: Marcel Dekker Ltd.
   Google Scholar
• Lucarelli M, Gatti A, Sararino G, Quattroni P, Marinelli L, Monari E, Boraschi D. Innate defence functions of macrophages can be biased by nano-size ceramic and metallic particles. Eur Cytokine Netw 2004; 15: 339–346
   PubMed Web of Science ®Google Scholar
• Masuda H, Inoya K. Theoretical study of the scatter of experimental data due to particle size distribution. J Chem Engineer Japan 1971; 4: 60–67
   Google Scholar
• Masuda H, Higashitani KD, Yoshida H. Powder technology handbook. Taylor & Francis, Boca Raton 2006
   Google Scholar
• Mossman BT, Churg A. Mechanisms in the pathogenesis of asbestosis and silicosis. Am J Resp Crit Care Med 1998; 157: 1666–1680
   PubMed Web of Science ®Google Scholar
• National Institute for Occupational Safety and Health (NIOSH). 1994. Manual of Analytical Methods (NMAM®). Cincinnati, Ohio.
   Google Scholar
• National Institute of Standards and Technology (NIST). 2001. Practice Guide SP 960-1, Jillavenkatesa A, Dapkunas S, and Lum H. Particle Size Characterization.
   Google Scholar
• National Research Council (NRC). 1989. Biologic Markers in Pulmonary Toxicology, Subcommittee on Pulmonary Toxicology Committee on Biologic Markers. Washington, DC: National Academy Press.
   Google Scholar
• Oberdörster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, Carter J, Karn B, Kreyling W, Lai D, et al. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol 2005; 2: 8–43
   PubMed Web of Science ®Google Scholar
• Office of Environmental Information: 40 CFR 799.9346: Subpart H-Health Effects Test Guidelines, TSCA 90-Day Inhalation Toxicity Term Detal Available:, http://iaspub.epa.gov/trs/trs_proc_qry.org_info?P_REG_AUTH_ID=1044&p_list_option_cd=ORG. via the INTERNET. Accessed 2007 Jan 30.
   Google Scholar
• Powers KW, Brown SC, Krishna VB, Wasdo SC, Moudgil BM, Roberts SM. Research strategies for safety evaluation of nanomaterials. Part VI. Characterization of nanoscale particles for toxicological evaluation. Tox Sci 2006; 90: 296–303
   PubMed Web of Science ®Google Scholar
• Renwick LC, Donaldson K, Clouter A. Impairment of alveolar macrophage phagocytosis by ultrafine particles. Toxicol Appl Pharmacol 2001; 172: 119–127
   PubMed Web of Science ®Google Scholar
• Roco MC. International strategy for nanotechnology research and development. J Nanoparticle Res 2001; 3: 353–360
   Web of Science ®Google Scholar
• Royal Society. 2004. Nanoscience and nanotechnologies: opportunities and uncertainties, RS Policy Document 19/04.
   Google Scholar
• Thomas K, Sayre P. Research strategies for safety evaluation of nanomaterials, Part I: Evaluating the human health implications of exposure to nanoscale materials. Tox Sci 2005; 87: 316–321
   PubMed Web of Science ®Google Scholar
• Weiss, R. 2004. For science, nanotech poses big unknowns. 1 February 2004. Washington, DC: Washington Post.
   Google Scholar
• Zhang Z, Kleinstreuer C, Donohue JF, Kim CS. Comparison of micro- and nano-size particle depositions in a human upper airway model. J Aerosol Sci 2005; 36: 211–233
   Web of Science ®Google Scholar